S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2

Diabetes. 2003 Sep;52(9):2381-8. doi: 10.2337/diabetes.52.9.2381.

Abstract

Angiotensin II (Ang II), a vasoactive peptide that is also considered a growth factor, has been implicated in both normal and diabetic cellular proliferation. We recently found that activation of janus kinase 2 (JAK2) is essential for the Ang II-induced proliferation of vascular smooth muscle cells (VSMCs) and that high glucose augments Ang II-induced proliferation of VSMCs by increasing signal transduction through activation of JAK2. Here, we demonstrate that S100B, a ligand for the receptor of advanced glycation end products (RAGEs), augmented both Ang II-induced tyrosine phosphorylation of JAK2 and cell proliferation in VSMCs in a receptor-dependent manner. We also found that S100B-RAGE interaction triggered intracellular generation of reactive oxygen species (ROS), VSMC proliferation, and JAK2 tyrosine phosphorylation via activation of phospholipase D (PLD)2. These results provide direct evidence for linkages between PLD2, ROS production, and S100B-RAGE-induced enhancement of Ang II-induced cell proliferation and activation of JAK2 in VSMCs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Antibodies / pharmacology
  • Aorta / cytology
  • Cell Division / drug effects
  • Cells, Cultured
  • DNA-Binding Proteins / metabolism
  • Drug Synergism
  • Electroporation
  • Hydrogen Peroxide / metabolism
  • Janus Kinase 2
  • Ligands
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / enzymology
  • NADPH Oxidases / metabolism
  • Phospholipase D / antagonists & inhibitors
  • Phospholipase D / metabolism*
  • Phosphoproteins / antagonists & inhibitors
  • Phosphoproteins / immunology
  • Phosphorylation / drug effects
  • Protein-Tyrosine Kinases / metabolism*
  • Proto-Oncogene Proteins*
  • Rats
  • Reactive Oxygen Species / metabolism
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / antagonists & inhibitors
  • Receptors, Immunologic / immunology
  • Receptors, Immunologic / metabolism*
  • S100 Proteins / metabolism
  • S100 Proteins / pharmacology*
  • STAT1 Transcription Factor
  • Trans-Activators / metabolism
  • Tyrosine / metabolism
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Antibodies
  • DNA-Binding Proteins
  • Ligands
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • Reactive Oxygen Species
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic
  • S100 Proteins
  • S100A1 protein
  • STAT1 Transcription Factor
  • Trans-Activators
  • Vasoconstrictor Agents
  • Angiotensin II
  • Tyrosine
  • Hydrogen Peroxide
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Protein-Tyrosine Kinases
  • Jak2 protein, rat
  • Janus Kinase 2
  • phospholipase D2
  • Phospholipase D